Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 171M | 169M | 170M | 166M |
Selling general and admin | 28M | 27M | 28M | 27M |
Other operating expenses | — | — | — | — |
Operating income | -199M | -196M | -198M | -193M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 6M | -12M | 16M | 28M |
Pretax income | -193M | -208M | -182M | -165M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -193M | -208M | -182M | -165M |
Basic EPS | — | -0.1 | -0.1 | -0.1 |
Diluted EPS | — | -0.1 | -0.1 | -0.1 |
Basic average shares | — | 1.7B | 1.6B | 1.5B |
Diluted average shares | — | 1.7B | 1.6B | 1.5B |
EBITDA | -184M | -164M | -193M | -200M |
Net income from continuing op. | -193M | -208M | -182M | -165M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |